Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer.
Saved in:
| Title: | Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer. |
|---|---|
| Authors: | McDuff SGR; Department of Radiation Oncology, Duke Cancer Center, Duke University Medical Center, Duke Medicine Circle, Durham, NC.; Harvard Radiation Oncology Program, Boston, MA., Hardiman KM; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL., Ulintz PJ; Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI., Parikh AR; Department of Internal Medicine and Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Zheng H; Biostatistics Center, Massachusetts General Hospital, Boston, MA., Kim DW; Harvard Radiation Oncology Program, Boston, MA., Lennerz JK; Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Hazar-Rethinam M; Massachusetts General Hospital Cancer Center, Boston, MA., Van Seventer EE; Massachusetts General Hospital Cancer Center, Boston, MA., Fetter IJ; Massachusetts General Hospital Cancer Center, Boston, MA., Nadres B; Massachusetts General Hospital Cancer Center, Boston, MA., Eyler CE; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA., Ryan DP; Department of Internal Medicine and Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Weekes CD; Department of Internal Medicine and Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Clark JW; Department of Internal Medicine and Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Cusack JC; The Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital, Boston, MA., Goyal L; Department of Internal Medicine and Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Zhu AX; Department of Internal Medicine and Hematology/Oncology, Massachusetts General Hospital, Boston, MA.; Jiahui International Cancer Center, Jiahui Health, Shanghai, China., Wo JY; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA., Blaszkowsky LS; Department of Internal Medicine and Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Allen J; Department of Internal Medicine and Hematology/Oncology, Massachusetts General Hospital, Boston, MA., Corcoran RB; Department of Internal Medicine and Hematology/Oncology, Massachusetts General Hospital, Boston, MA.; Massachusetts General Hospital Cancer Center, Boston, MA., Hong TS; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA. |
| Source: | JCO precision oncology [JCO Precis Oncol] 2021 Jan 12; Vol. 5. Date of Electronic Publication: 2021 Jan 12 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: eCollection Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
